Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by CADInvestor12on Jun 13, 2024 5:06pm
59 Views
Post# 36088042

RE:Senior managements knows how to shoot off their mouth

RE:Senior managements knows how to shoot off their mouthLike the fluff press releases that were issued under previous management team? Did you ever think that maybe they haven't shared certain details for competitive reasons? You might want to listen closer because you're not retaining or comprehending what they've said. B2B/ co-man revenue is great, but $10M in potential revenue isn't going to drive the share price higher. Pidduck wasn't brought in to run a cannabis company, he was hired to transition the company into a leading cannabis pharmaceutical company. In the meantime, see if they will update you everytime someone takes a cr@p or wipes their nose. Goof. 
<< Previous
Bullboard Posts
Next >>